TP53 and glioblastoma: Furthermore, media collected from the same samples had reduced glutamate levels compared to control media (Figure 4D), suggesting that restoring p53 in p53-null GBM cells helped mitigate SXC properties that make these GBM12 tumors so invasive in vivo [6].